318 related articles for article (PubMed ID: 21030327)
1. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
Wens J; Gerard R; Vandenberghe H
Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation and care of patients with type Ii diabetes regarding recommendations concerning cardiovascular risk factors and adherence to values in general medicine in the Grand Duchy of Luxembourg].
Stein R; Aubart-Schuller M; Vandenberghe H
Bull Soc Sci Med Grand Duche Luxemb; 2010; (2):289-301. PubMed ID: 20882748
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.
Leśniak W; Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jankowski M; Sieradzki J; Banasiak W;
Cardiol J; 2015; 22(2):150-9. PubMed ID: 25299503
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
Boytsov S; Logunova N; Khomitskaya Y;
Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
[TBL] [Abstract][Full Text] [Related]
5. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
Kuznik A; Mardekian J
Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
[TBL] [Abstract][Full Text] [Related]
6. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
[TBL] [Abstract][Full Text] [Related]
7. Difficulties in reaching therapeutic goals for hypertension and dysplipidaemia in patients with type 2 diabetes in general practice.
Knudsen ST; Mosbech TH; Hansen B; Kønig E; Johnsen PC; Kamper AL
Dan Med J; 2013 Dec; 60(12):A4740. PubMed ID: 24355449
[TBL] [Abstract][Full Text] [Related]
8. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
[TBL] [Abstract][Full Text] [Related]
9. Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7.
Pedersen E; Garcia BH; Halvorsen KH; Eggen AE; Schirmer H; Waaseth M
BMC Cardiovasc Disord; 2021 Jan; 21(1):44. PubMed ID: 33478404
[TBL] [Abstract][Full Text] [Related]
10. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
[TBL] [Abstract][Full Text] [Related]
11. Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level.
Roccatagliata D; Avanzini F; Monesi L; Caimi V; Lauri D; Longoni P; Marchioli R; Tombesi M; Tognoni G; Roncaglioni MC;
Vasc Health Risk Manag; 2006; 2(4):507-14. PubMed ID: 17323606
[TBL] [Abstract][Full Text] [Related]
12. Glycaemic, blood pressure and cholesterol control in 25 629 diabetics.
Pinchevsky Y; Butkow N; Chirwa T; Raal FJ
Cardiovasc J Afr; 2015; 26(4):188-92. PubMed ID: 26407221
[TBL] [Abstract][Full Text] [Related]
13. Change in cardiovascular risk factors in relation to diabetes status: the Tromso Study.
Joseph J; Svartberg J; Njølstad I; Schirmer H
Eur J Prev Cardiol; 2012 Jun; 19(3):551-7. PubMed ID: 21505026
[TBL] [Abstract][Full Text] [Related]
14. Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register.
Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Eliasson B; Andersson Sundell K
BMC Health Serv Res; 2018 Nov; 18(1):900. PubMed ID: 30486824
[TBL] [Abstract][Full Text] [Related]
15. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease.
Changsirikulchai S; Sangthawan P; Janma J; Sripaiboonkij N; Rattanamongkolgul S; Thinkhamrop B
Nephrology (Carlton); 2018 Jan; 23(1):53-59. PubMed ID: 27608176
[TBL] [Abstract][Full Text] [Related]
16. Management of risk factors among ambulatory patients at high cardiovascular risk in Canada: a follow-up study.
Elbarasi EA; Goodman SG; Yan RT; Tan MK; Hackam DG; Leiter LA; Langer A; Yan AT;
Can J Cardiol; 2013 Dec; 29(12):1586-92. PubMed ID: 24041994
[TBL] [Abstract][Full Text] [Related]
17. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.
Mark L; Vallejo-Vaz AJ; Reiber I; Paragh G; Kondapally Seshasai SR; Ray KK
Atherosclerosis; 2015 Jul; 241(1):62-8. PubMed ID: 25966441
[TBL] [Abstract][Full Text] [Related]
18. ["Diabetes in Germany"(DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice].
Ott P; Benke I; Stelzer J; Köhler C; Hanefeld M
Dtsch Med Wochenschr; 2009 Feb; 134(7):291-7. PubMed ID: 19197810
[TBL] [Abstract][Full Text] [Related]
19. Treat-to-target HbA
Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
[TBL] [Abstract][Full Text] [Related]
20. Utilization of glucose, blood pressure, and lipid lowering medications among people with type II diabetes in the United States, 1999-2010.
Wong HK; Ong KL; Cheung CL; Cheung BM
Ann Epidemiol; 2014 Jul; 24(7):516-21.e1. PubMed ID: 24935464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
